Insulin cost study receives widespread news coverage

A JAMA research letter on the rising cost of insulin by William Herman, M.D., MPH, and colleagues from the University of Melbourne, Australia and the University of Chicago has attracted international media coverage. The team used federal data to chart trends in the cost of a range of blood sugar medications over more than a decade, in constant dollars. Insulin costs tripled, while the cost of metformin went down over time and newer medications experienced a slight rise.

Follow these links to hear Dr. Herman discuss the study on the national public radio show Science Friday, and to read coverage in Time, Reuters,  HealthDay, the STAT healthcare news service, PBS, AARP News, Modern Healthcare, Medscape, NEJM JournalWatch, Southern California Public Radio and FiercePharma. Dr. Herman was also interviewed by CBS Newsradio for a story that aired on dozens of stations nationwide.

Read the original U-M story that led to much of this coverage, on Michigan Health Lab.